Published in BMC Cancer on July 28, 2014
Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer. PLoS One (2016) 1.44
Inflammatory Response After Laparoscopic Versus Open Resection of Colorectal Liver Metastases: Data From the Oslo-CoMet Trial. Medicine (Baltimore) (2015) 1.41
The influence of marital status on stage at diagnosis and survival of patients with colorectal cancer. Oncotarget (2015) 1.19
Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer. Oncotarget (2015) 0.81
The impact of marital status at diagnosis on cancer survival in patients with differentiated thyroid cancer. Cancer Med (2016) 0.80
Anatomical, Physiological, and Molecular Imaging for Pancreatic Cancer: Current Clinical Use and Future Implications. Biomed Res Int (2015) 0.78
Pretreatment serum interleukin-1β, interleukin-6, and tumor necrosis factor-α levels predict the progression of colorectal cancer. Cancer Med (2016) 0.78
Effect of marital status on the survival of patients with gallbladder cancer treated with surgical resection: a population-based study. Oncotarget (2017) 0.77
Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis. PLoS One (2015) 0.76
Predictive Role of Functional Visceral Fat Activity Assessed by Preoperative F-18 FDG PET/CT for Regional Lymph Node or Distant Metastasis in Patients with Colorectal Cancer. PLoS One (2016) 0.75
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw (2010) 38.65
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol (2004) 7.16
The interleukin-8 pathway in cancer. Clin Cancer Res (2008) 7.12
Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg (2003) 6.04
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg (2008) 4.86
Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg (2004) 3.72
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer (2003) 3.44
Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg (2007) 3.33
Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis (2007) 2.30
Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg (2009) 2.22
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22
Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol (2006) 2.02
Occult hepatic metastases in colorectal carcinoma. Br J Surg (1986) 1.90
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med (2012) 1.85
Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int (2008) 1.83
Serum interleukin-6 levels in colorectal cancer patients--a summary of published results. Int J Colorectal Dis (2009) 1.72
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer (2005) 1.71
Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol (2012) 1.70
Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol (2003) 1.65
Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res (2001) 1.64
Serum C-reactive protein as independent prognostic variable in patients with ovarian cancer. Clin Cancer Res (2008) 1.60
Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer (2012) 1.58
Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol (2009) 1.57
Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc Natl Acad Sci U S A (1996) 1.52
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer (2007) 1.43
Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg (2007) 1.35
Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg (2005) 1.26
Indicators for treatment strategies of colorectal liver metastases. Ann Surg (2000) 1.26
The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer (2005) 1.24
Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer. Br J Cancer (2007) 1.21
C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer (2007) 1.21
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis (2012) 1.12
Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg (2001) 1.09
CXCL10 expression and prognostic significance in stage II and III colorectal cancer. Mol Biol Rep (2009) 1.01
Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. Arch Surg (2007) 0.97
Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer. Br J Cancer (2013) 0.96
A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg (2004) 0.95
Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival. Dig Surg (2010) 0.94
Eotaxin-2 and colorectal cancer: a potential target for immune therapy. Clin Cancer Res (2007) 0.93
Significance of inflammatory cytokines in the progression of colorectal cancer. Hepatogastroenterology (2003) 0.88
Expression of CXCR3 on mononuclear cells and CXCR3 ligands in patients with metastatic renal cell carcinoma in response to systemic IL-2 therapy. J Immunother (2007) 0.88
Analysis of single nucleotide polymorphism in the promoter and protein expression of the chemokine eotaxin-1 in colorectal cancer patients. World J Surg Oncol (2007) 0.86
A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases. BMC Cancer (2009) 0.85
Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients. Scand J Gastroenterol (1999) 0.83
Bowel obstruction following appendectomy: what is the true incidence? Ann Surg (2009) 2.50
Bile duct injuries associated with laparoscopic cholecystectomy: timing of repair and long-term outcomes. Arch Surg (2010) 2.26
Postoperative complications following surgery for rectal cancer. Ann Surg (2010) 2.23
A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. Am J Gastroenterol (2009) 1.84
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.59
Management of perforation after endoscopic retrograde cholangiopancreatography (ERCP): a population-based review. HPB (Oxford) (2006) 1.56
Predicting in-hospital mortality in patients undergoing complex gastrointestinal surgery: determining the optimal risk adjustment method. Arch Surg (2011) 1.54
Feasibility of identifying pancreatic cancer based on serum metabolomics. Cancer Epidemiol Biomarkers Prev (2010) 1.51
Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg (2005) 1.50
ACS-NSQIP has the potential to create an HPB-NSQIP option. HPB (Oxford) (2009) 1.44
Dramatic innovations in modern surgical subspecialties. Can J Surg (2010) 1.40
Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.40
AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: rationale and overview of the conference. Ann Surg Oncol (2009) 1.29
Wound protectors reduce surgical site infection: a meta-analysis of randomized controlled trials. Ann Surg (2012) 1.21
Colorectal liver metastases contract centripetally with a response to chemotherapy: a histomorphologic study. Cancer (2008) 1.18
The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors. Surgery (2008) 1.16
Utilization of thyroidectomy for benign disease in the United States: a 15-year population-based study. Am J Surg (2011) 1.13
Effect of ambient air pollution on the incidence of appendicitis. CMAJ (2009) 1.10
Effect of noise on auditory processing in the operating room. J Am Coll Surg (2013) 1.08
Comparison of stapled versus handsewn loop ileostomy closure: a meta-analysis. J Gastrointest Surg (2007) 1.07
Morbidity and mortality following multivisceral resections in complex hepatic and pancreatic surgery. J Gastrointest Surg (2007) 1.06
Peri-operative blood transfusion and operative time are quality indicators for pancreatoduodenectomy. HPB (Oxford) (2010) 1.04
Serum metabolomic profile as a means to distinguish stage of colorectal cancer. Genome Med (2012) 1.04
Impact of surgeon training on outcomes after resective hepatic surgery. Ann Surg Oncol (2008) 1.04
Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid). AJR Am J Roentgenol (2015) 1.03
Clinical manifestations of tension pneumothorax: protocol for a systematic review and meta-analysis. Syst Rev (2014) 1.02
Morbidity and mortality following colorectal surgery in patients with end-stage renal failure: a population-based study. Dis Colon Rectum (2010) 1.00
Outcome of laparoscopic splenectomy with preoperative splenic artery embolization for massive splenomegaly. Surg Endosc (2010) 0.99
Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009). Cancer Causes Control (2011) 0.99
Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease. Arch Surg (2011) 0.99
Phase II study of neoadjuvant 5-FU + leucovorin + CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma. BMC Cancer (2004) 0.99
The impact of country and culture on end-of-life care for injured patients: results from an international survey. J Trauma (2010) 0.99
Intermittent hepatic vein--total vascular exclusion during liver resection: anatomic and clinical studies. J Gastrointest Surg (2005) 0.98
CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer. J Thorac Oncol (2011) 0.98
Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J Surg Oncol (2007) 0.96
Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility. PLoS One (2013) 0.96
Reovirus as a viable therapeutic option for the treatment of multiple myeloma. Clin Cancer Res (2012) 0.95
Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours. CMAJ (2006) 0.95
Recent trends of hepatic resection in Canada: 1995-2004. J Gastrointest Surg (2008) 0.94
Hospital performance reports based on severity adjusted mortality rates in patients with cirrhosis depend on the method of risk adjustment . Ann Hepatol (2012) 0.92
Training in Hepatopancreatobiliary Surgery: Assessment of the Hepatopancreatobiliary Surgery Workforce in North America. Ann Surg (2015) 0.91
Blood loss in surgical oncology: neglected quality indicator? J Surg Oncol (2009) 0.90
Acute care surgery: the impact of an acute care surgery service on assessment, flow, and disposition in the emergency department. Am J Surg (2012) 0.90
Elective resection of colon cancer by high-volume surgeons is associated with decreased morbidity and mortality. J Gastrointest Surg (2011) 0.90
The utility of the harmonic scalpel in selective neck dissection: a prospective, randomized trial. Otolaryngol Head Neck Surg (2011) 0.90
Well differentiated intrahepatic cholangiocarcinoma in the setting of biliary papillomatosis: a case report and review of the literature. Can J Gastroenterol (2005) 0.90
Reovirus modulates autophagy during oncolysis of multiple myeloma. Autophagy (2013) 0.89
AHPBA/SSO/SSAT sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma. HPB (Oxford) (2010) 0.89
Impact of regional lymph node evaluation in staging patients with periampullary tumors. Ann Surg Oncol (2007) 0.88
Clinical Presentation of Patients With Tension Pneumothorax: A Systematic Review. Ann Surg (2015) 0.87
Admission base deficit and lactate levels in Canadian patients with blunt trauma: are they useful markers of mortality? J Trauma Acute Care Surg (2012) 0.86
Water-jet dissection for parenchymal division during hepatectomy. HPB (Oxford) (2006) 0.86
A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases. BMC Cancer (2009) 0.85
A decade of experience with injuries to the gallbladder. J Trauma Manag Outcomes (2010) 0.85
Primary colorectal lymphoma-clinical outcomes in a population-based series. J Gastrointest Surg (2011) 0.85
Rupture and intra-peritoneal bleeding of a hepatocellular carcinoma after a transarterial chemoembolization procedure: a case report. Cases J (2009) 0.85
Ambient ozone concentrations and the risk of perforated and nonperforated appendicitis: a multicity case-crossover study. Environ Health Perspect (2013) 0.85
Population-based review of the outcomes following hepatic resection in a Canadian health region. Can J Surg (2009) 0.85
Complementary and alternative medicine use among general surgery, hepatobiliary surgery and surgical oncology patients. Can J Surg (2009) 0.84
Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review. HPB (Oxford) (2013) 0.83
Neurofibroma of the porta hepatis. J Hepatobiliary Pancreat Surg (2008) 0.83
Survival after hepatic resection: impact of surgeon training on long-term outcome. Can J Surg (2013) 0.83
Measuring and reporting on quality in health care: a framework and road map for improving care. J Surg Oncol (2009) 0.83
Complex hepatic surgery aided by a 1.5-tesla moveable magnetic resonance imaging system. Am J Surg (2006) 0.83
Hospitalization for uncomplicated hypertension: an ambulatory care sensitive condition. Can J Cardiol (2013) 0.82
Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC. Int J Hepatol (2011) 0.82
Open transgastric debridement and internal drainage of symptomatic non-infected walled-off pancreatic necrosis. HPB (Oxford) (2011) 0.81
The consensus statement on mixed martial arts: emotion, not evidence-based. Can J Surg (2011) 0.81
Pancreatic fistulae: are we making progress? J Hepatobiliary Pancreat Surg (2008) 0.81
Hepatic resection in Canada: rates and geographic variation. Can J Surg (2009) 0.81
Perioperative supplemental oxygen in colorectal patients: a meta-analysis. J Surg Res (2009) 0.81
Disparities in the surgical treatment of colorectal liver metastases. J Natl Med Assoc (2013) 0.81
Hepatic vein injury during laparoscopic cholecystectomy: the unappreciated proximity of the middle hepatic vein to the gallbladder bed. J Gastrointest Surg (2006) 0.81
The effect of wait times on oncological outcomes from periampullary adenocarcinomas. J Surg Oncol (2013) 0.80
Clinical results of N-acetylcysteine after major hepatic surgery: a review. J Hepatobiliary Pancreat Surg (2008) 0.80
Severe street and mountain bicycling injuries in adults: a comparison of the incidence, risk factors and injury patterns over 14 years. Can J Surg (2013) 0.80
The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada. Can J Gastroenterol (2011) 0.80
Role of imaging in the preoperative staging of small bowel neuroendocrine tumors. J Am Coll Surg (2010) 0.80
Extramucosal hepaticojejunostomy. Am J Surg (2005) 0.79
Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Callery et al. Ann Surg Oncol (2009) 0.79
Estimating successive cancer risks in Lynch Syndrome families using a progressive three-state model. Stat Med (2013) 0.79
Does surgeon fatigue influence outcomes after anterior resection for rectal cancer? Am J Surg (2008) 0.78
Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation. Ann Surg (2016) 0.78
Cognitive impairment associated with carcinoid syndrome. Ann Surg (2014) 0.78
Surgical trauma referrals from rural level III hospitals: should our community colleagues be doing more, or less? J Trauma (2009) 0.78
Multi-criteria development and incorporation into decision tools for health technology adoption. J Health Organ Manag (2013) 0.78